Novo-Nordisk A/S
Market cap $215.7B
$48.77
NVO
$48.77
+1.22% today
Buy with €1M virtual cash · No real money
Novo-Nordisk A/S (NVO) is a publicly traded company listed on the XNYS. As of July 27, 2026, Invest's signal rates NVO a Hold, with the stock down 30% over the past year. You can practice trading NVO risk-free with €1,000,000 in virtual cash.
Key stats
As of July 27, 2026
Market Cap
$215.7B
Volume
10.8M
52-wk High
$71.28
52-wk Low
$35.12
Day High
$49.52
Day Low
$48.71
Performance
1M
+2.9%
6M
-21.6%
1Y
-30.4%
Invest signal · NVO
HoldAlgorithmic signal from price trend, valuation, and fundamentals — educational only, not financial advice.
NVO overview
AI overviewLatest NVO news
2 Top Growth Stocks to Buy Right Now Without Any Hesitation
The Motley Fool · 3d ago
Want Income for Life? Here Are 3 Stocks to Buy Now and Never Sell.
The Motley Fool · 4d ago
New study finds GLP-1 receptor agonists associated with lower risk of alcohol-related hospitalization among adults with alcohol use disorder
GlobeNewswire Inc. · 5d ago
"Deceptive Advertising!" Claims Novo Nordisk in Explosive New GLP-1 Lawsuit Against Eli Lilly. Here's What That Means for Both Stocks.
The Motley Fool · 5d ago
Novo Nordisk's Dividend Story Is Changing -- Here's What Investors Are Missing
The Motley Fool · 5d ago
About Novo-Nordisk A/S
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Employees
69,500
30-Day Win Rate · NVO
11 days
12 days
Last 23 sessions
How to practice trading NVO
- 1
Use the NVO buy panel above
Set a quantity and hit Buy at the real market price — right here, nothing to download.
- 2
Trade with €1,000,000 virtual cash
You get a million in virtual money instantly to invest, risk-free.
- 3
Create a free account to save it
Sign up in seconds to keep your portfolio and track its performance.
- 4
Track and compete
Watch your portfolio grow and climb the global leaderboard — or start a private league.
- 5
Prefer mobile? Get the iOS app
Invest is also free on the App Store, synced with your web account.
Top NVO traders on Invest
Full leaderboardFrequently asked questions
Is NVO a good stock to buy right now?
As of July 27, 2026, Invest's signal rates NVO a Hold, based on its price trend, valuation, and fundamentals, with the stock down 30% over the past year. This is an educational signal, not financial advice — the best way to test the thesis is to practice trading NVO risk-free first.
What is Novo-Nordisk A/S's (NVO) market cap?
Novo-Nordisk A/S has a market capitalization of approximately $215.7B.
How has NVO stock performed?
NVO is down 30% over the past year and down 22% over six months. Its 52-week range runs roughly from $35.12 to $71.28. Past performance doesn't predict future results.
How can I practice trading NVO for free?
On Invest you get €1,000,000 in virtual cash and can buy NVO at real market prices right in your browser — no download and no real money at risk. Create a free account to save your portfolio and track its performance over time.
More stocks to practice
Designs the iPhone, Mac, and a huge services ecosystem.
Windows, Office, Azure cloud, and enterprise software.
The leading designer of AI and gaming GPUs.
E-commerce giant and the largest cloud provider (AWS).
Google Search, YouTube, Android, and cloud.
Facebook, Instagram, WhatsApp, and the metaverse.
Compare NVO with peers